Boston Scientific
BSX
BSX
1,141 hedge funds and large institutions have $78.2B invested in Boston Scientific in 2023 Q4 according to their latest regulatory filings, with 174 funds opening new positions, 439 increasing their positions, 375 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.13% more ownership
Funds ownership: 91.18% → 92.31% (+1.1%)
5% less call options, than puts
Call options by funds: $513M | Put options by funds: $538M
7% less funds holding in top 10
Funds holding in top 10: 29 → 27 (-2)
Holders
1,141
Holding in Top 10
27
Calls
$513M
Puts
$538M
Top Buyers
| 1 | +$944M | |
| 2 | +$713M | |
| 3 | +$397M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$383M |
| 5 |
JPMorgan Chase & Co
New York
|
+$262M |
Top Sellers
| 1 | -$704M | |
| 2 | -$326M | |
| 3 | -$310M | |
| 4 |
Millennium Management
New York
|
-$203M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$180M |